These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17308279)

  • 1. Chemotherapy for advanced gastric cancer.
    Al-Batran SE; Jäger E; Scholz M
    J Clin Oncol; 2007 Feb; 25(6):729; author reply 730. PubMed ID: 17308279
    [No Abstract]   [Full Text] [Related]  

  • 2. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
    Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimization of chemotherapy of stomach cancer].
    Chernyĭ VA; Shchepotin IB
    Vrach Delo; 1989 Jun; (6):10-2. PubMed ID: 2781744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-making in surgery: the management of gastric carcinoma.
    Huang J; Goddard L; Thomas PA
    Br J Hosp Med; 1997 May 21-Jun 3; 57(10):502-4. PubMed ID: 9329999
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant chemotherapy in advanced stomach cancer].
    Zehner J; Weber L; Fischer M; Gfirtner H; Breit A
    Med Klin (Munich); 1986 Jun; 81(13):445-8. PubMed ID: 3785030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin].
    Repetto L; Campora E; Nobile MT; Rosso R
    G Ital Chemioter; 1985; 32(1):57-8. PubMed ID: 3841661
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of advanced colorectal and gastric cancer with 5-fluorouracil and calcium n-methyltetrahydrofolate.
    Casali A; Tonachella R; Tropea F; Verri C; Paoletti G; Gionfra T; Modugno G; Gallo Curcio C
    J Chemother; 1989 Jul; 1(4 Suppl):1212-4. PubMed ID: 16312838
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of metastatic gastric cancer.
    Wils J
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():395-8. PubMed ID: 10895185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/ leucovorin (FOLFOX-4 chemotherapy)].
    Garrido M; Melgoza G; Galindo H; Madrid J; Sánchez C; Nervi B; Alvarez M; Orellana E
    Rev Med Chil; 2007 Nov; 135(11):1380-7. PubMed ID: 18259648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer.
    Muro H; Acuña LR; Castagnari A; Blajman C; Schmilovich A; Hidalgo A; Fiori H; Bader M; Marantz A
    Cancer Treat Rep; 1986 Nov; 70(11):1333-4. PubMed ID: 3768875
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
    Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patient with stomach cancer with metastases. What is the value of chemotherapy?].
    Wilke H; Stahl M; Vanhoefer U
    MMW Fortschr Med; 2003 Nov; 145(48):39-42. PubMed ID: 14724998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinoma.
    Rougier P; Droz JP; Theodore C; Piot G; Herait P; Ruffie P; Carde P; Cvitkovic E
    Cancer Treat Rep; 1987 Dec; 71(12):1301-2. PubMed ID: 3690544
    [No Abstract]   [Full Text] [Related]  

  • 16. [European School of Oncology (ESO)--gastric cancer treatment strategy].
    Ogawa M
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):277-9. PubMed ID: 1736843
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Fazio N; Biffi R; Curigliano G; Lorizzo K; Zampino MG; de Braud F; Chiappa A; Roth A; Goldhirsch A
    J Natl Cancer Inst; 2007 Sep; 99(17):1345-6; author reply 1346-7. PubMed ID: 17728219
    [No Abstract]   [Full Text] [Related]  

  • 19. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Anticancer Res; 2007; 27(5B):3535-9. PubMed ID: 17972514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.